SH

Shield Bio

YC S16

San Francisco, US · 28 employees · Inactive · 5 known investors

shieldbio.com ↗

Shield Bio develops nanopore sequencing technology for clinical use, designed to run rapid genetic tests in healthcare settings. The company initially targets infectious disease diagnosis and sepsis detection to reduce treatment delays.

Founders & leadership· Y Combinator alumni (S16)

Fred Turnerin𝕏Founder/CEO

Investors · 5

Y

Y CombinatorSan Francisco · $500K – $500K

AN

Andreessen HorowitzreportedMenlo Park

RE

Refactor CapitalreportedSilicon Valley · $1M – $2M

SO

Soma CapitalreportedSacramento

VA

Valia VenturesreportedLondon · $50K – $50M